Nomura Research Institute Ltd. NRILY Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Nomura Research Institute Ltd. NRILY Company Overview 

Stock Message Board http://investorshangout.com/search?q=NRILY&am...mp;yt1=Go!

Nomura Research Institute Ltd. NRILY Current Price and Quotes
Last Price 68.82
Previous Close 68.82 Open N/A
Daily Range N/A - N/A 52wk Range 69.30 - 38.94
Volume 0 Dividend 0.9653
Average Vol (3m) 132 Yield 1.4
Nomura Research Institute Ltd. NRILY
Company Information

Marunouchi Kitaguchi Building
1-6-5 Marunouchi
Chiyoda-ku, Tokyo 100-0005
Japan

Website: http://www.nri.co.jp
Phone: +81 (3) 5533-2111
Email: ir@nri.co.jp

Nomura Research Institute Ltd. NRILY
NRI supports the lives of people, the business activities and the development of society through its Consulting, Financial IT Solutions, Industrial IT Solutions and IT Platform Services. In these op erations, the key is Navigation × Solution. In enhancing the value of our services, the synergy between these two functions is at work in each of the four areas of its operations as well as in a wide range of operations.

Nomura Research Institute Ltd. NRILY
Financial Reportings and Disclosures

Reporting Status International Reporting: Tokyo Stock Exchange
CIK 0001179493
Fiscal Year End 3/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification
Incorporated In: Japan
Year of Inc. 1965
Employees 5739 a/o Mar 31, 2012
Company Officers/Contacts

Tadashi Shimamoto President, CEO, COO
Company Directors

Akihisa Fujinum Chairman
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Nomura Research Institute Ltd. NRILY
NRILY Security Details Other Company Securities

Share Structure

Market Value1 $7,742,250,000 a/o Sep 27, 2013
Shares Outstanding 225,000,000 a/o Feb 28, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) *  Sep 27, 2013
Dividend (0.42802) *  Mar 28, 2013 Jun 18, 2013
Dividend (0.00) *  Mar 28, 2013
Non US Stock Exchange Listing

4307 - Tokyo Stock Exchange - Qualified
Short Selling Data

Short Interest 291 (136.59%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

JPMorgan Depositary Receipts
Deutsche Bank

Nomura Research Institute Ltd. NRILY Recent News

Jul 23, 2013 NRI to Reinforce Research and Consulting Capability Through Capital Injection to, and Alliance with an Indian Research Company


Nomura Research Institute Ltd. NRILY Financials
Data is unavailable at this time. Please check this page later.


NRILY Nomura Research Institute Ltd. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=NRILY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/NRILY/quote
Stock Chart http://www.otcmarkets.com/stock/NRILY/chart
Company Info http://www.otcmarkets.com/stock/NRILY/company-info
Recent News http://www.otcmarkets.com/stock/NRILY/news
Financials http://www.otcmarkets.com/stock/NRILY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/NRILY/filings
Short Sales http://www.otcmarkets.com/stock/NRILY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/NRILY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/NRILY/research
Summary http://finance.yahoo.com/q?s=NRILY
Historical Prices http://finance.yahoo.com/q/hp?s=NRILY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=NRILY
Basic Chart http://finance.yahoo.com/q/bc?s=NRILY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NRILY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=NRILY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=NRILY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=NRILY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=NRILY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=NRILY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=NRILY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=NRILY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=NRILY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=NRILY
Balance Sheet http://finance.yahoo.com/q/bs?s=NRILY
Cash Flow http://finance.yahoo.com/q/cf?s=NRILY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/NRILY
Market Watch http://www.marketwatch.com/investing/stock/NRILY
Bloomberg http://www.bloomberg.com/quote/NRILY:US
Morningstar http://quotes.morningstar.com/stock/s?t=NRILY
Bussinessweek http://investing.businessweek.com/research/st...cker=NRILY
Barchart http://www.barchart.com/quotes/stocks/NRILY
OTC Short Report http://otcshortreport.com/index.php?index=NRILY
Investopedia http://www.investopedia.com/markets/stocks/NRILY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Important Legal Opportunity for Coinbase Investors in Class Action

Updated Category News Views 114

Key Opportunity for Coinbase Investors Investors holding Coinbase Global, Inc. (NASDAQ: COIN) securities may have a significant opportunity to participate in a class action lawsuit alleging serious violations of securities regulations. This opportunity arises from actions that took place during the specified Class Period. Investors are encouraged to evaluate their...

Continue Reading
BridGene Biosciences Secures $28 Million for Drug Development

Updated Category News Views 244

BridGene Biosciences Raises Significant Funding BridGene Biosciences, Inc., renowned for its innovative approach in developing small molecule drugs, recently announced the completion of a substantial $28 million Series B+ financing round. This funding round was spearheaded by Bayland Capital, alongside notable contributions from GTJA Investment Group, Proxima Ventures,...

Continue Reading
NMD Pharma Breaks Ground with NMD670 in Rare Neuromuscular Treatment

Updated Category News Views 177

NMD Pharma's Innovative Phase 2 Study with NMD670 NMD Pharma A/S, an ambitious clinical-stage biotech company, is making strides in the fight against neuromuscular diseases. They have officially begun their Phase 2a clinical trial of NMD670, a novel treatment aimed at addressing the challenges faced by patients with Charcot-Marie-Tooth (CMT) disease types 1 and 2. This...

Continue Reading
Becker Milk Company Limited Announces Half-Year Financial Overview

Updated Category News Views 89

Introduction to Becker Milk Company's Financial Landscape Becker Milk Company Limited is making headlines with its financial results for the first half of its fiscal year. The latest report showcases their performance, reflecting on revenues and net income trends. Financial Highlights Overview Total revenues for the first six months reveal a detail-oriented insight into...

Continue Reading
Mini Melts Collaborates with 7-Eleven for Blue Raspberry Flavor

Updated Category News Views 354

Exciting New Flavor Launch from Mini Melts and 7-Eleven In an exciting collaboration, Mini Melts USA, a leader in premium beaded ice cream, has partnered with 7-Eleven, Inc. to introduce a new flavor reminiscent of the classic Blue Raspberry Slurpee. This innovative flavor captures the essence of the much-loved frozen drink, providing fans with a delightful and nostalgic...

Continue Reading